- Home
- CRNC vs PRTC Comparison
CRNC vs PRTC Comparison
Compare CRNC & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNC
- PRTC
- Stock Information
- Founded
- CRNC 2020
- PRTC 2015
- Country
- CRNC United States
- PRTC United States
- Employees
- CRNC N/A
- PRTC N/A
- Industry
- CRNC EDP Services
- PRTC Biotechnology: Pharmaceutical Preparations
- Sector
- CRNC Technology
- PRTC Health Care
- Exchange
- CRNC Nasdaq
- PRTC Nasdaq
- Market Cap
- CRNC 418.7M
- PRTC 439.8M
- IPO Year
- CRNC N/A
- PRTC N/A
- Fundamental
- Price
- CRNC $8.62
- PRTC $17.90
- Analyst Decision
- CRNC Buy
- PRTC Buy
- Analyst Count
- CRNC 7
- PRTC 1
- Target Price
- CRNC $9.43
- PRTC $45.00
- AVG Volume (30 Days)
- CRNC 1.5M
- PRTC 2.0K
- Earning Date
- CRNC 08-07-2025
- PRTC 04-30-2025
- Dividend Yield
- CRNC N/A
- PRTC N/A
- EPS Growth
- CRNC N/A
- PRTC N/A
- EPS
- CRNC N/A
- PRTC 0.21
- Revenue
- CRNC $254,250,000.00
- PRTC $4,828,000.00
- Revenue This Year
- CRNC N/A
- PRTC $35.98
- Revenue Next Year
- CRNC $8.02
- PRTC $115.38
- P/E Ratio
- CRNC N/A
- PRTC $7.81
- Revenue Growth
- CRNC N/A
- PRTC 44.98
- 52 Week Low
- CRNC $2.34
- PRTC $13.30
- 52 Week High
- CRNC $27.50
- PRTC $28.39
- Technical
- Relative Strength Index (RSI)
- CRNC 46.21
- PRTC 46.07
- Support Level
- CRNC $8.11
- PRTC $19.00
- Resistance Level
- CRNC $10.33
- PRTC $19.80
- Average True Range (ATR)
- CRNC 0.72
- PRTC 0.33
- MACD
- CRNC -0.12
- PRTC -0.12
- Stochastic Oscillator
- CRNC 19.17
- PRTC 16.30
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About PRTC PureTech Health plc
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.